We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gene Vaccine Protects Mice from Influenza Virus Strains

By LabMedica International staff writers
Posted on 13 Nov 2017
Print article
Image: A scanning electron micrograph (SEM) of the influenza virus (Photo courtesy of the CDC).
Image: A scanning electron micrograph (SEM) of the influenza virus (Photo courtesy of the CDC).
A team of molecular virologists protected mice from deadly infection caused by a range of influenza viruses by using a deactivated adenovirus vector to vaccinate them with a cocktail of centralized viral genes.

In a study conducted by investigators at the University of Nebraska, Lincoln (USA), mice were immunized with replication-defective adenovirus expressing the H1-con, H2-con, H3-con, and H5-con HA (hemagglutinin) consensus influenza virus genes in combination (multivalent) and compared to mice immunized with the traditional 2010–2011 FluZone and FluMist seasonal vaccines. The mice were then challenged with 10–100 MLD50 (the median lethal dose required to kill half the population) of H1N1, H3N1, H3N2 and H5N1 influenza viruses.

The investigators reported in the November 2, 2017, online edition of the journal Scientific Reports that the traditional vaccines induced robust levels of HA inhibition (HI) titers, but failed to protect against five different heterologous lethal influenza challenges. Conversely, the multivalent consensus vaccine induced protective HI titers against eight of 10 influenza viruses that represented a wide degree of divergence within the HA subtypes and protected 100% of mice from eight of nine lethal heterologous influenza virus challenges.

The vaccine protection was dose dependent, in general, and a low dose still provided 100% survival against seven of nine lethal heterologous influenza challenges. These data indicated that very low doses of adenovirus-vectored consensus vaccines induced superior levels of immunity against a wide divergence of influenza subtypes as compared to traditional vaccines.

"Our idea is that these centralized antigens can set up a foundation of immunity against influenza," said senior author Dr. Eric Weaver, assistant professor of biological sciences at the University of Nebraska, Lincoln. "Because they are centralized and represent all the strains equally, they could provide a basis for immunity against all evolved strains. An ideal influenza vaccine would be inexpensive, provide long-lasting immunity, require few immunizations, and would work against all variants of the virus. The ultimate goal is to be able to vaccinate once and provide lifelong protection."

Related Links:
University of Nebraska, Lincoln

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.